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INTRODUCTION AND LITERATURE 
New technology presents difficulties for policy makers in that it is impossible to 
determine every subsequent impact of a novel technology when it is introduced to 
society.  Direct-to-consumer (DTC) genetic testing exemplifies this problem while 
presenting the additional complication of having an impact on both individual and public 
health.  Little research has been done on what consumer perceptions of information 
presented to them are.  Some studies have demonstrated a need for further work and 
expert consensus has identified issues with advertisements but no research has been 
done on consumer perceptions. 
 
METHODOLOGY 
A cohort of faculty and staff at the Rochester Institute of Technology (RIT) were 
presented with a screenshot of a website from a leader in the DTC genetic testing 
industry and asked about their perceptions of the genetic tests presented on that page.  
The survey was distributed via email and presented using RIT Clipboard software. 
 
RESULTS AND DISCUSSION 
103 responses to the survey were received and analyzed.  There was a wide range in the 
answers provided to questions but several themes emerged upon analysis.  This 
population was significantly more educated than the general U.S. population.  Many 
respondents indicated some form of knowledge in science and or technology, either 
through formal education or work experience.  The responses indicated a significant lack 
of understanding of the information presented by the company.  Some respondents 
demonstrated a misunderstanding of the basic concepts underlying the information 
presented and a failure to correctly interpret the advertisement.  These results indicate a 
potential need for policies regarding the structure, content and interpretation of these 
advertisements.  Further research should focus on establishing similar results for other 
genetic tests and DTC genetic testing companies as well as developing methodologies to 










In any field, new technology presents substantial difficulties to policy makers.  When 
the public’s health can be impacted by a new technology, those difficulties can become 
real and immediate threats to public well-being.  As medical technology continues to 
advance, policy needs to be continually updated to deal with the new benefits and 
possible drawbacks to each development.  Within this arena, genetic testing has become 
an issue which has advanced to a point where there may be need for government 
oversight.  Among the promises of genetic testing are better health outcomes for patients 
due to improved clinical treatment.  The eventual goal of utilizing this information is to 
improve patients’ quality of life and to increase longevity.  However, the benefits and 
costs of genetic testing are difficult to determine and many factors complicate the 
clinical treatment of patients.  Direct-to-consumer (DTC) genetic testing presents an 
additional problem in that a large amount of complex information is made available to 
the consumer without the interpretational assistance of a trained professional.  There are 
concerns regarding multiple aspects of these tests and there is little oversight from the 
federal government of the tests and the surrounding issues.  This lack of oversight may 
eventually lead to poorer outcomes for patients and an increased burden on the 
healthcare system. 
 
Genetic testing is a process by which a specific mutation or mutations are identified in 
the genome of an individual.  In a clinical setting these tests should lead to a diagnosis of 
a specific disorder or influence a treatment decision.  There are two key indicators of 
whether a genetic test is useful.  Analytic validity is the ability of the test to accurately 
identify the specific mutation for which it was designed.  Clinical validity means that the 
mutation being tested for has an impact on the how the patient’s treatment and can 
positively influence a health outcome.  
 
A genetic test which demonstrates both of these qualities is that for Hereditary Non-
polyposis Colorectal Cancer (HNPCC) gene.  The presence of this gene indicates an 






demonstrative of the tests analytic validity.  The identification of a family history and 
subsequent testing for and discovery of this gene alter the course of screening for 
carriers.  Normally an individual is recommended for screening every ten years, 
beginning at age 40 for colorectal cancer.  However, if a patient is identified as having 
the HNPCC mutation, they should begin screening between ages 20 to 25 and continue 
to be screened every one to three years.  This change in screening demonstrates clinical 
validity.  The added genetic knowledge is beneficial because it increases screening 
procedures which may find a tumor at an earlier stage, increasing the likelihood of a 
positive outcome for the patient. (Rex, Johnson, Lieberman, Burt, & Sonnenberg, 2000).  
Unfortunately the number of tests which have been shown to demonstrate both of these 
traits is a very small percentage of the hundreds of commercially available tests.  If a test 
has neither analytic nor clinical validity it is not generally recommended by the majority 
of health and scientific communities. 
 
The use of genetic testing in the clinical setting is a fairly recent development.  The 
process typically involves a physician ordering a test in order to confirm a diagnosis or 
to determine a specific treatment.  These tests are performed by different laboratories, 
usually outside of a physicians practice.  Each physician or hospital has purview to 
decide which company he or she uses to complete genetic testing for their patients.  
Typically, a physician only orders tests which have the ability to positively impact 
physical health outcomes for an individual.  Due to the variations in human reaction and 
experience the mental health impacts (such as stress and anxiety due to a misinterpreted 
test result) are even more complex than the physical implications and are outside the 
scope of this work.  The physician then reviews the results and implications with the 
patient and then the two make decisions together based on all available clinical 
information, including genetic test results. 
 
Having a physician aid in decision making is ideal for the patient because it provides an 
opportunity for someone with applicable knowledge to help the patient understand 
information and make informed decisions.  However, the advent of direct-to-consumer 
(DTC) advertising presents a dilemma to each person considering genetic testing.  Due 






prescription drugs.  However there has been a recent and dramatic increase in the 
number of genetic testing laboratories using this method to attract customers.  There are 
many protections from DTC advertising of prescription drugs by numerous agencies of 
the federal government.  These protections limit how companies can represent and 
market their products.  However, the federal government has not implemented similar 
regulations on genetic testing advertisements.  In addition, the potential consumer of a 
prescription drug is protected by the fact that a physician can act as a gatekeeper because 
a doctor is still required to write a prescription for a particular medication.  In many 
states patients can order genetic tests directly from companies and receive results 
without any physician or genetic counseling guidance.  Economic theory suggests that 
the lack of a gatekeeper results in an incentive for firms to create supplier induced 
demand.  This would create an overproduction of genetic test (Folland, Goodman, & 
Stano, 2007).  Firms can accomplish this through aggressive marketing and advertising 
and this is arguably what we see in the current genetic testing market.  
 
The Centers for Medicare and Medicaid Services (CMS) the Food and Drug 
Administration (FDA) and the Federal Trade Commission (FTC) are the oversight 
bodies for laboratory developed tests (LDT’s) such as genetic testing.  The Clinical 
Laboratory Improvement Act (CLIA) is the law which grants CMS the ability to conduct 
periodic “proficiency testing.”  This act was designed to “strengthen federal oversight of 
clinical laboratories to assure that the tests results are accurate and reliable.”  It was 
based on congressional hearings which determined that lab tests had a large impact on 
clinical outcomes (Javitt, Stanley, & Hudson, 2004). 
 
A significant gap in this act is that it lacks specificity as to which tests to regulate and 
how to regulate them.  It also contains no provisions regarding the advertisement of any 
medical device or procedure, including genetic testing.  Over time the FTC and the FDA 
have stated that they have joint purview over the advertising of LDT’s.  However, 
neither has taken the initiative to regulate the advertising of genetic tests.  Both have 
cited limited resources as the reason why genetic testing advertisements are not 
regulated similarly to prescription drugs (Gollust, Hull, & Wilfond, 2002).  The only 






should be wary of claims made by testing companies and should enlist the help of a 
qualified physician in deciding whether to order genetic tests and interpreting the results.  
The FDA has only begun to take action and has started to warn companies and held open 
forums relating their concerns and allowing for input from parties with vested interests 
regarding advertising practices (Pollack, FDA Faults Companies on Unapproved 
Genetic Tests, 2010).   
 
Although not cited by the government agencies as a barrier to regulation, it is also the 
case that the link between genetic testing and poor health outcomes is difficult to 
establish. The connection between prescription drugs and negative health outcomes has 
been more easily identified, placing more pressure on the government to regulate those 
ads.  In the case of genetic testing there are several logical steps between the 
advertisement and the health outcome.  First, the patient must decide to take the test, the 
patient must then interpret the test results, and then the patient must make a decision 
whether or not to consult others regarding the test results.  Finally the patient must make 
a decision regarding his or her health.  That decision will have an impact on the patient’s 
health and may be positive or negative or neutral depending on a multitude of factors.  
Figure 1 demonstrates these steps graphically.  They can choose to include or disregard 
the genetic information in that decision.  As a final note, the patient must also decide 
whether to tell his or her biological family about the test results, which may have 
implications for their health as well.  These complex steps make the justification more 































Figure 1. Flowchart of patient decision making steps which may involve a genetic test. 
   
The lack of federal oversight has forced individual states to legislate and enforce 
individual regulations.  This has left the country with a patchwork of laws with varying 
strictness.  Some states have remained entirely silent on the issue.  Others require that 
patients meet with physicians for any genetic testing which has clinical applications.  
Still other states have completely banned any DTC advertising and only physicians may 
order these tests.  Because the internet is such a widely utilized resource, both for 
companies and persons seeking genetic tests, it is difficult to determine who is being 
impacted by a given advertisement.  It is entirely plausible that a patient in one state 
with strict regulations will visit the site of a company in a state with no regulations and 







A typical scenario where the lack of regulation would negatively impact health 
outcomes might play out as follows.  A woman with a family history of breast cancer is 
interested in seeing if she has an increased risk for cancer.  She searches the internet for 
genetic testing sites and although she lives in New York, a state which strictly prohibits 
DTC advertising she is able to access 23 and Me’s website.  The company’s 
advertisement states “BRCA1 and BRCA2 mutations account for most (though not all) 
cases of inherited breast cancer in women (23 and Me, 2011).”   Relieved that there is a 
test which can assuage her fears she purchases the test.  She is mailed a test kit and 
sends her sample back to the laboratory.  In a week she receives the results, she is 
negative for both BRCA-1 and BRCA-2, meaning that she is not at increased risk for 
hereditary breast cancer.  Because she has not spoken with a physician she takes this to 
mean that she will not get breast cancer.  However, while this result does decrease her 
risk of hereditary breast cancer it does not account for the large percentage of cases 
which are not hereditary.  In fact, having either BRCA-1 or BRCA-2 increases the 
lifetime risk of a woman developing breast cancer from 12% to only 60% (National 
Cancer Institute, 2005).  The woman in this scenario still has a 12% lifetime risk of 
developing breast cancer.  23 and Me does present information to this effect on the page 
but it is unclear whether consumers are able to draw the complex connection.  If she 
misunderstands it, this information reduces the likelihood that she will engage in 
preventative behavior (mammograms and self-exams).  Five years later she notices a 
lump.  By the time her cancer is diagnosed it has metastasized throughout her body and 
in addition to the personal costs and pain associated with therapy her medical costs 
skyrocket.  This anecdote provides one example of how the misinterpretation of a test 
result could lead to poor health outcomes for the patient. 
 
This scenario illustrates how poor information and the lack of regulation could have a 
devastating impact on a patient.  Although the company’s website was technically 
accurate, it did not provide all the information the patient needed to make an informed 
decision about her healthcare.  Because the regulations were different in each state, the 
state law which was supposed protect her was rendered useless by the interstate nature 
of the internet.  A federal regulation or interstate pact may be required to protect the 






national level would help to prevent this and similar issues from occurring due to 
inconsistencies in regulation. 
 
There is a precedent for national regulation in light of inconsistent state laws regarding a 
medical topic. The issue of abortion has remained contentious for decades but prior to 
the 1973 ruling of the Supreme Court in Roe v. Wade individual states had differing 
regulations on whether women were allowed to get abortions.  The result of this was that 
women in states with restrictive abortion laws were forced to either travel to a state with 
fewer restrictions or to obtain the abortion illegally.  This decision could result in 
significant pain, sterilization, and even death.  By setting a national standard, the 
Supreme Court was able to make a medical procedure available to all women regardless 
of which state they resided in (Pence, 2011).  The case with DTC genetic testing is 
similar in that requiring individuals to consult a physician would be equivalent to 
providing individuals with access to a service consistently on a national level.   
 
While a link has been established between poor analytic validity and poor health 
outcomes, the link between incomplete or misleading advertising is less proven.  Beyond 
that, no one has examined whether the advertisements themselves are misleading to 
consumers.  There have been a few studies which have established that advertisements 
may contain incorrect information, but no one has determined whether patients can 
understand information presented accurately in advertisement, or whether the misleading 
advertisements have an effect on actual patient decisions.  Anecdotal evidence suggests 
that this may be the case but there have been no systematic studies of how consumers 
process the highly technical information presented in genetic testing DTC 
advertisements (McBride, Wade, & Kaphingst, 2010). 
 
A New York Times article examined the extent to which direct to consumer genetic 
testing was occurring in March of 2010.  The industry’s leader, 23 and Me was noted to 
have tested 35,000 customers. Two other companies, Navigenics and Decode Genetics 
have provided services to 20,000 and 10,000 customers respectively.  The article itself 
argues that the market is relatively small.  However, the numbers tell a different story.  






23 and Me raised $27.8M.  This indicates that the size of this problem is not 
insignificant and while these companies may begin to struggle (as the article contends), 
this could cause them to utilize even more aggressive advertising, further inflating the 
demand and potentially causing more harm to misled consumers (Pollack, Consumers 
Slow to Embrace the Age of Genetics, 2010).  
 
Another news article in the Washington Post compared DTC genetic test marketing to 
the way Apple aggressively marketed the iPod and how other high tech companies 
market their products (Cruikshank, 2010).  What this article fails to note is the health 
impact from a genetic test is still unproven and it is unclear whether aggressive 
marketing practices are appropriate for products which have a primarily medical 
purpose.  There are also questions regarding whether consumers can comprehend 
material presented in these types of advertisements.  While both examples demonstrate 
the power of consumerism, when the products being marketed may have impacts on 
health it is even more important for consumers to understand what they are buying. 
 
Within the past several years genetic testing has become more publicized in media 
outlets.  Highlighting this increase in attention is a series of articles by Greg Pollack in 
the New York Times (of which the articles noted previously are a part) which has 
followed the issue closely (Pollack, FDA Faults Companies on Unapproved Genetic 
Tests, 2010).  As this issue gains more attention it is likely that more people will be 
interested in obtaining these tests, whether or not they have clinical value.  Pollack’s 
articles focus on government action against DTC companies and one could argue that 
they are a call for action.  As a result of the increased public attention and other factors 
in 2010 there was a dramatic increase in action by the FDA on looking into DTC genetic 
tests (Singer, 2010).  However, no finalized regulations have been established and there 
is a call for more research to be done examining what the potential impacts of this 
technology could be and whether it should be regulated.  One aspect of this research is 
examining how consumers process and comprehend the information presented in DTC 








BACKGROUND AND LITERATURE 
 
There are still significant questions as to whether these tests and their advertisement 
should be regulated, yet few studies have examined the impact of advertisements on 
clinical outcomes.  There are many editorial and opinion pieces published regarding this 
issue, but there is little research to support them.  The studies that have been conducted 
focus primarily on the actual validity of the genetic tests.  Research focused on the 
advertisements themselves use expert opinions of the factual information in the 
advertisements but do not account for the general public’s perception of the issue.   
 
The DTC advertising of prescription drugs is closely related to that of genetic testing.  
Prescription medication advertisements are strictly regulated therefore more research has 
been done regarding the impact of DTC advertising of prescription drugs than genetic 
tests.  One study found that ads for prescription drugs are insufficient for consumers to 
make informed decisions (Kanfar, Louden, & Sircar-Ramsewak, 2007).  This research 
can be applied to genetic testing advertisements as well.  Because of the complexities 
involved with genetic testing and the lack of regulations, the confusion is likely to be 
even greater with consumers of genetic tests. 
 
Many companies have defended their DTC policies by stating that consumers are not 
utilizing the information for clinical reasons.  This theory was shown to be questionable 
by a study which determined that 78% of consumers who would have a genetic test 
would seek their physicians help in interpreting the results (Caufield, Ries, Ray, 
Shuman, & Wilson, 2009).  This indicates that the primary reason for patients to 
purchase genetic testing is that they believe knowing their genetic structure will have 
some positive impact on their health and their lives.  Whether or not this belief is an 
accurate one is something that is still not proven.   
 
An article published in the Journal of the American Medical Association (JAMA) 
examined several advertisements for their accurate portrayal of a test and whether the 






of the advertisements had at least one of three problematic aspects.  The first is that the 
advertisements themselves were misleading.  The second is that the information being 
advertised is complex, a fact which cannot be accurately portrayed in the abbreviated 
communications.  Lastly there is a large amount of contention over whether the tests 
being advertised have substantial clinical utility (Gollust, Hull, & Wilfond, 2002).
 
 
In order to determine the clinical validity of genetic tests for cancer Marchionni et al. 
examined three separate tests.  They found that the three varied in their ability to both 
accurately analyze the genetic information and provide valuable clinical data.  Of the 
tests studied, Oncotype Dx, had the best clinical utility, but even its clinical utility was 
insufficient to be considered definitive.  Further, the authors determined that more 
population genomic research was required in order to prove clinical utility (Marchionni 
& Marinopoulos, 2008).  Although this was not mentioned in the article, all three tests 
were available to the public and were advertised as pharmaco-genetic indicators.   
 
A report from the conservative bioethical think tank, The Hastings Center, identified one 
print advertisement for BRCA-1 and BRCA-2 genes and systematically reviewed it for 
its merits and problems.  They determined that the ad overstated the test’s ability to 
predict and misrepresented what the test actually did.  This determination was made by a 
group of experts in the field (Hull & Prasad, 2001).  While this study does present 
valuable information, it only establishes a problem for one advertisement and does not 
consider how the public itself would view the advertisement.  The authors assume that 
because the public has a limited knowledge of the tests that they would be misled.  
There has been no research to date regarding whether this assumption is accurate. 
 
In a study published late in 2010, Rahm reviewed the findings of a focus group of Kaiser 
Permanente Health Plan members regarding their thoughts on genetic testing.  The 
group considered both genetic information presented in advertisements and test results.  
The conclusion of the author was that there was a large amount of individual variation 
with regards to opinions on genetic testing and potential impacts of test results on 






may influence how patients comprehend and process information presented in these 
advertisements (Rahm, 2010).   
 
Another study by McBride et al. examined the impact of genetic test results on 
consumer decision making.  The authors note that there has been no established research 
demonstrating harm to patients as a result of receiving DTC genetic tests.   The authors 
recommend accelerated research including long-term responses to information, optimal 
support decision making and looking at primary care provider competency as it relates 
to genetic testing.  The implications of this paper are that it solidifies the need for future 
research on this topic and the social impacts of DTC genetic tests, specifically the link 
between DTC genetic tests and clinical outcomes needs to be established (McBride, 
Wade, & Kaphingst, 2010). 
 
In addition to these studies, several editorials and opinion pieces have theorized that the 
general public does not have the knowledge necessary to make informed decisions 
without the help of a physician.  A statement from the Genetics and Public Policy center 
claims that, “consumers are vulnerable to being misled by advertisements and lack the 
knowledge to make appropriate decisions about whether to get tested or how to interpret 
the results (Williams, 2008).”  This and similar theories have not been examined 
systematically and we are uncertain whether the public does have the understanding 
required to properly interpret the test results. 
 
Along with the peer-reviewed literature, and in conjunction with the public interest in 
this topic, there have been two hearings held before various House of Representative 
subcommittees by the Government Accounting Office (GAO).  In 2006 the GAO 
testified that advertisement claims were often vague and at times blatantly false and that 
they contributed little to patient health awareness (Government Accounting Office, 
2006).  More recently the GAO presented a report which stated that the tests themselves 
are misleading and that they are being marketed inappropriately to consumers.  The 
GAO sent DNA samples to five different companies and often received conflicting 










In order to assess how consumers understand these advertisements a survey was utilized 
which measured their scientific background, comprehension of the information 
presented and key demographic questions.  A survey was selected as the research 
instrument in order to gather a wide range of information on a relatively large cohort at a 
specific moment in time. 
 
The instrument can be found in Appendix A and contains questions in three sections: 
demographics, interpretation of the advertisement, and scientific background.  The 
participants were presented with information from 23 and Me’s website regarding their 
genetic tests for alcohol dependency and were asked a number of questions on the 
material presented.  Questions included multiple choice, “Yes / No” free text and likert 




The faculty and staff at the Rochester Institute of Technology (RIT) were chosen as a 
cohort for several reasons.  There is likely to be a mix of education both in terms of 
highest level achieved as well as field of study.  Students were not included because of 
their limited age range and a decreased likelihood of purchasing the test in the near 
future.  Including a wider range of ages may provide information regarding differences 
in age groups and comprehension.   This cohort was also selected because they are more 
likely to be interested in obtaining the genetic tests and more likely to have the means to 
purchase the tests.  Lastly, they represent a convenience sample due to time and resource 
constraints. 
 
There are potential limitations associated with this cohort.  There is likely to be a bias 
toward persons with a high amount of technical skill because of the nature of the 
university being sampled.  With a history steeped in technology and a faculty and 
curriculum that support technological education there is significant cultural importance 






interest in technology and science are likely to be drawn to this university.   In addition, 
because the survey was distributed by email, the sample is limited to faculty or staff with 
an RIT email account, potentially excluding less educated members as they would be 
less likely to have an email address that is checked frequently.  There may also be a self-
selection bias as persons who have a background in biological or medical sciences may 
be more apt to respond to the survey.   As a result of these biases the results may not be 
able to be generalized to the U.S. population.  However, if this cohort still demonstrates 
a lack of understanding of the advertisements, it is unlikely that the general public will 




The RIT Institutional Review Board (IRB) input and approval were obtained during 
survey development and prior to distribution.  The survey was distributed to faculty and 
staff at RIT via an email containing a link to an RIT clipboard survey and a brief 
description of the research and its intent.  Distributing the survey in this manner created 
a straightforward way for participants to respond and ensured that the majority of the 
faculty and staff receive the email.  The limitations of this method are that it limits 
persons without consistent email access from participating and therefore may skew the 
results towards faculty and away from staff.  Additionally, a survey limits the ability for 
follow up discussion based on participant responses. 
 
Participants were presented with a screenshot taken from 23 and Me’s website.  
Specifically the entire webpage on alcohol dependency was presented unaltered as it was 
available in February of 2011. They were asked to take several minutes to review the 
screenshot and familiarize themselves with the information.  There was no time limit 
placed on the review period since respondents were able to return to the material during 
the survey (although this was not suggested or mentioned in the instructions).  The 
respondents were asked to begin answering questions once they felt comfortable with 
the material. 
 
This company was selected because it is currently the largest distributor of DTC genetic 






Alcohol dependence was selected to be the condition and test because it is not gender 
dependent, is relatively well-known by the public, and has both genetic and 
environmental factors which contribute to its clinical presentation.  23 and Me identifies 
their test as a “disease risk” test and also as a “preliminary research report.”  The number 
of tests noted as preliminary is 72%.  The majority of tests are also classified as “disease 
risk” (23 and Me, 2011).  Therefore alcohol dependency is representative of the majority 
of tests made available by this company 
 
The first section of the instrument asked for demographic information from the 
respondent.  Because genetic tests vary in reliability depending on ethnicity and sex it 
was important to have the participants self-identify both of those factors.  In addition, 
participants were asked to identify their level of education and area of study (if 
applicable) as well as their current occupational field.  Both of these measures were 
collected as potentially important predictors of comprehension.   
 
The second section of questions attempted to establish what participants were able to 
glean from the information presented to them.  They were asked to respond to several 
questions on both the content of the advertisements and what their impressions of the 
test itself are, as well as whether they might take action based on the results of the test.  
Questions included “Yes/No”, free text, Likert scales and multiple choice.  The type of 
answer was dependent on the question being asked and whether the potential answers 
could be easily categorized.  In some instances it was important to allow participants the 
ability to react in depth to the question.  For other questions, scales and categorized 
answers allowed for easier analysis and created a homogenous data set. 
 
Lastly, respondents were asked several questions to measure the depth their scientific 
background and literacy.  These questions were primarily an effort to establish whether 
the assumption that persons at RIT may be more technically savvy is correct.  These 
questions also helped to identify possible correlations between scientific understanding 
and advertisement comprehension.  Without better understanding how participants 






the comprehension questions.  For a listing of all questions and the purpose behind each 
particular question please see Table 1. 
 
TABLE 1. A list of each question and reasoning behind why it was asked.  When applicable, the reason 




1) What is your age? Identifies age-rage of sample 
for normalization purposes 
Helps control for the topic, as 
alcohol is pervasive on college 
campuses 
Varied, but with a 
distribution centering 
around between the ages 
of 30 and 50  




Identifies sex of sample for 
normalization purposes 
50% male and 50% 
female 
3) Education (please select one) 
 Some High-school 
 Graduated High-school 
 Attended some college 
 Associate’s degree 
 Bachelor’s degree 
Identifies education of sample 
to compare to U.S. population 
Provides insight into whether a 
correlation may exist between 
education level and knowledge 
of topic 
The majority of 
individuals will have a at 
least a bachelor’s degree, 
4) If you have received a college 
education (associate’s or more) please 
indicate your major 
Further clarifies question 3 for 
analysis 
A high percentage of 
liberal arts, science and 
engineering respondents 
5) What is your highest terminal degree? Further clarifies question 3 and 
4 for analysis 
Many advanced degrees 
6) What is your current occupation?  Administrators / Faculty 
7) Ethnicity 
 African America 
 Asian / Pacific Islander 
 Caucasian 
 Latin / South American 
 Native American 
 Other 
The genetic test presented only 
applies to a certain ethnicity, 
ethnic background of sample 
may have impacted responses 
A large percentage of 
Caucasians  
8) What are your impressions of alcohol 
dependency and genetics? 
Asked before analysis questions 
to attempt to obtain a baseline 
of participants’ understanding 
of topic 
 Varied by individual 
9) How many studies are described in 
this advertisement? 
Attempt to determine whether 
the structure of the website 
information was clear 
3 
10) If you had a family member who had 
a dependency on alcohol would you be 




This question was developed to 
determine the participants 
interest level in alcohol 
dependency 






11) If you had a blood relative who had a 
dependency on alcohol would you be 




Attempt at determining whether 
participants would vary their 
response based on a hereditary 
vs. familial proximity to the 
topic 
Varied by individual 
12) What is the relationship between 
marker RS27072 and alcohol 
dependency? 
Attempt to determine whether 
the content of the website 
information was clear 
Having a particular allele 
lowers the odds of having 
withdrawal seizures 
13) How closely are genes and alcohol 
dependency related (Likert)?  
 Not closely At All 
 Not Very Closely 
 Somewhat Closely 
 Fairly Closely 
 Very Closely 
What were the participants’ 
overall impressions of the 
website and how closely the 
genetics and alcohol 
dependency were related?  A 
likert scale was utilized to 
simplify for coding purposes 
Varied by individual 




Did the participants notice the 
ethnicity qualifier present on 
the website? 
Yes 
15) If so, how? Clarifying question 14.  If the 
participant guessed correctly, A 
free text response allows them 
to explain their response 
Studies only included 
European and Asian 
ancestries, results may 
not apply to other 
ethnicities 
16) How interested are you in this 
condition (Likert)? 
 Very Uninterested 
 Not Interested 
 Neutral 
 Somewhat Interested 
 Very Interested 
An attempt to control for formal 
education.  If someone was very 
interested in the topic they may 
be more educated than would 
be typical 
Varied by individual 
17) Approximately how many people’s 
genetics were studied to determine the 
relationship between marker 





Attempt to determine whether 
the content of the website 
information was clear 
10,000 
18) What would you do if you received a 
test result that indicated you had this 
gene? 
 Nothing 
 Seek more information on the 
condition on the internet 
 Talk to my doctor about the 
risks 
 Call the company to speak to a 
genetic counselor 
A look forward at what the 
potential “end-user” acceptance 
of the policy would be if they 
were required to utilize a 
physician as a gatekeeper 






19) Where did you receive the majority 






This question was aimed at 
obtaining which piece of the 
website the participants found 
most helpful. 
Varied by individual 
20) What is an established research 
report? 
An attempt at determining what 
the general consensus was 
regarding this language as it is 
not defined by any traditional 
convention, yet is used by 23 
and Me. 
There is no official 
scientific definition for 
this term  
21) What journals did the research stem 
from? 
This question’s intent was to 
determine whether individuals 
could determine the journal 
names based on their 
abbreviations 
Archives of General 
Psychiatry, Molecular 
Psychiatry, and 
Alcoholism: Clinical & 
Experimental Research 
22) What is a SNP? Because this acronym is used in 
the website but not defined, this 
was asked to determine what 




23) Susie requested that this analysis be 
done for her.  The result stated that she 
had an increased risk for alcohol 
dependency.  The letter from the lab said 
that her test was ____. 
 Positive 
 Negative 
Because there are differences 
between the social and clinical 
connotations of positive and 
negative, this was asked to see 
whether participants could 





The analysis of the survey results included both basic statistical and interpretative 
qualitative analyses.  Interpretive analysis was used on any answers which were 
provided via free text.  In order to obtain the most information from this limited sample 
it was important to use qualitative methods such as interpretive analyses to better 
understand the respondent’s mindset.  By using basic statistical analyses to establish 
areas of interest and furthering that work with interpretive analyses I was able to develop 
an adequate picture of whether this sample of consumers understand the advertisements 
and whether the ads have a potential impact on their future decision making if they were 
to obtain the test.   
 
Free text was analyzed with either interpretive analysis or a coding scheme, depending 






data which was obtained.  Using this scheme, themes were developed and categorized to 
both help describe the sample and identify trends. 
 
Simple statistical analyses looking at correlations between all the variables were 
developed in order to examine if any relationships may exist.  The relationship between 
education and comprehension were examined (as measured through several questions) 
were as well as between ethnicity, age and gender and potential decision making.  The 
apparent gaps in understanding were especially important to review, given sample’s 









103 responses to the survey were received.  All responses were included in the analysis.  
While it was clear that some persons were unable to see the actual advertisement it was 
decided that their response to the questions was as valuable as the ones who did not 
complete the survey.  There was an issue with one particular browser type and the ability 
to view the screen shot.  The responses they provided to the scientific background and 
demographic questions should not have been impacted by the advertisement.  Further we 
can assume that they chose not to answer questions pertaining to the advertisement when 
they could not see it.  Therefore no response was eliminated from the analysis.  Where 
noted there were questions left unanswered by certain respondents. 
 
Demographically the sample was relatively diverse.  54% of the respondents were 
female and 46% were male.  The average age was 47.8 years, with a standard deviation 
of 15 years indicating that 68% of the respondents were between the ages of 32 and 62.  
Of those that responded to the question “What is your highest terminal degree,” 68% 
noted that they had achieved a master’s degree or higher (n = 60/88).  Fields of 
education were relatively diverse as well with the majority being liberal arts disciplines 
as well as a significant number being business, science and engineering (See Table 1).  
Ethnically the vast majority (92%) identified as Caucasian. 
 
TABLE 2. Break-out of demographics by discipline.  Note that there is a wide distribution of disciplines 
identified by the respondents. 
Discipline Count Percentage 
Engineering / Computer Science 20 19% 
Liberal Arts / Fine Arts 35 34% 
Science 15 15% 
Unclear / No Answer 19 18% 
Total 103 100% 
   
 
The next section of the survey focused on the respondent’s impressions of the material 
which was presented to them.  The first question allowed free form response to “What 
are your impressions of alcohol dependency and genetics?”  Upon coding of the 






believed there was no relationship and 23 noted that both genetics and environment 
could have an impact on alcohol dependency.   
 
The next two questions focused on determining whether respondents distinguished 
between family member and blood relatives in terms of relations.  When asked if they 
would be interested in getting a genetic test for themselves if a blood relative or family 
member had a dependency on alcohol the majority in both cases (66% and 65% 
respectively) stated that they would not be interested in the test, however 8 respondents 
(8%) changed their response in some way. 
 
When asked what the relationship between RS27072 and alcohol dependency was there 
were a wide variety of responses.  24 (18%) individuals stated that they did not know or 
left the answer blank.  61 (58%) respondents identified “withdrawal seizures” or 
“symptoms” in their response.  18 respondents identified that there was some 
relationship but only noted a general correlation to alcohol dependency. 
 
TABLE 3. Categorization of answers to how respondents viewed the relationship between marker 






Did not know / Blank 24 23 
Noted relationship but no 
identification of withdrawal 
seizure correlation 
18 17 
Noted “withdrawal seizures” 




When asked how closely genes and alcohol were related the majority (52%) stated 
“somewhat related.”  The rest of the responses appear to follow a normal distribution in 
terms of their interpretation of the directness of this relationship.  This is demonstrated 








FIGURE 1.  Results of the asking survey respondents to define the relationship between alcohol 
dependency and genetics on a likert scale.  Raw counts are presented here to demonstrate the normal 
distribution of the responses.  
 
Because the advertisement noted the applicable heredities for these tests, the respondents 
were asked whether ethnicity had an impact on the relationship between genetics and 
alcohol dependency.  49% answered that it did not, 45% answered that it did and 5 
respondents did not answer.  When asked to expand upon that relationship, if there was 
one, respondents answered from varying perspectives.  Some listed general thoughts 
regarding ethnicity, others noted the ethnicities from the advertisement and still others 
listed that they were unclear as to the exact nature of the relationship.   
 
When asked how many people were studied in order to determine the relationship 
between a specific marker and alcohol dependency 64% chose the correct answer of 
10,000 people, while 18% chose incorrectly and 19% simply did not answer. 
 
Respondents were asked to answer on a Likert scale how interested they were in the 
condition.  43% chose the “somewhat interested” option with the others selecting 
neutral, not interested very uninterested and very interested 24%, 15% 9% and 6% of the 




















Closeness of Genes and Alcohol 








FIGURE 2.  Graph demonstrating the level of interest in alcohol dependency noted by respondents who 
answered (6 participants did not provide a response).   As predicted the majority of individuals were 
somewhat interested or neutral toward the topic. 
 
When asked where they received the majority of the information the vast majority 
responded ‘text’ (80%).  The remaining noted that they received information from 
charts, numbers and graphs in descending order. 
 
The respondents were presented with a question which allowed multiple responses to 
what their action plan would be if they received a test result indicating that they had 
“this gene.”  49 respondents stated they would go to their doctor, 31 would do nothing, 
21 would do further investigation on the internet and 6 would seek out a genetic 
counselor provided by the company doing the testing. 
 
The last segment of questions focused on determining what the basic scientific 
knowledge of the sample was.  Because the company uses the term “established research 
report” in their description of the tests, persons were asked what that term meant. 21 
responded with some variation of “I don’t know” or “not sure.”  23 did not answer the 
question.  Of those that did answer 26 stated peer review as part of the criteria of a 
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The respondents were also asked what journals the research was published in.  34 
individuals responded by copying the abbreviations listed in the advertisement, 8 
respondents wrote out the full titles of the journals.  Two respondents made note of the 
fact that the titles were only presented in abbreviated form. 
 
Individuals were asked what a “SNP” was.  Only 12 individuals responded with accurate 
answers, of these 4 noted that they used an internet source to research the information 
before responding.  The remaining respondents did not answer the question, stated they 
didn’t know the answer or responded inaccurately. 
 
When asked to determine whether a test result was positive or negative for a 
hypothetical person, 7% of respondents responded inaccurately and 8% chose not to 










The survey was distributed online in order to limit the study sample to persons who 
might have the opportunity to interact with the material presented in the survey.  This 
limitation was enforced in order to target the survey to a more representative sample of 
potential utilizers of these tests.  Including persons who do not use the internet would 
have added limited value to the survey responses.  In addition, targeting people who 
have a general understanding of the internet allows the researcher to make certain 
assumptions when asking questions, allowing for more specific information gathering.  
For example, it was possible to assume that the respondents would be able to understand 
how to navigate the survey and respond accurately to the questions.  It is likely that 
individuals familiar with the internet would have taken online surveys previously and 
would therefore be able to navigate and answer questions with little direction in the 
content of the survey.   From a policy perspective, only surveying those who might 
interact with the test allows us to understand the opinions of individuals who might 
interact with the advertisements and tests, thereby allowing us to gauge the perception of 
those who might be impacted by a regulation.   
 
The population the study sample represented was that of RIT faculty and staff.  This 
population was well represented with an almost even distribution of men and women.  
The majority of respondents had at least a Bachelor’s degree, indicating a higher level of 
education than is typical for the U.S. citizen.  In 2010 29.9% of US citizens had obtained 
a minimum of a 4 year degree while 84.5% of this sample noted that they had obtained 
at least that level of formal education (US Census Bureau). This significant difference 
implies that the overall the individuals studied were more likely than the average U.S. 
citizen to have some formal education in a scientific discipline.  There was a large 
proportion of respondents with careers in liberal arts, science and engineering.  For those 
disciplines we can assume a higher likelihood that these individuals have received some 
form of formal training which would assist in their understanding of the material 






acknowledging this familiarity it is possible to make better inferences to the survey 
responses that follow. 
 
The demographics of this population were sought for several reasons.  Due to the value 
placed on technology at the university (Rochester Institute of Technology, 2012), the 
faculty and staff at RIT are more likely to be technologically inclined and therefore 
potentially more likely to encounter and subsequently purchase DTC genetic tests.  
Additionally there is a higher likelihood of an above-average education level.  However, 
there is still a large proportion of individuals with limited educations.  It may be that 
those individuals are the most at risk in this environment as they have access and interest 
in these services but are lacking the formal education that may be required to better 
interpret both the advertisements and the tests themselves.  Due to the nature of the 
university there may be some pressure for these individuals to have a greater 
understanding of scientific material and they may be reaching out to unqualified sources 
for answers, the result of which could be a misunderstanding of the material.  For these 
reasons, this selection of individuals makes RIT an excellent sample set for this 
research. 
 
Because it was assumed that a typical RIT employee would have a higher education 
level than the average internet user it is likely that they would have a greater chance of 
understanding the information presented.  By using this strategy, if the individuals with 
a relatively high education level cannot understand the information then it is likely that 
those with less education will struggle as much, if not more so.  By selecting for more 
highly educated individuals, there is an increased likelihood that the results are as or 
more meaningful for persons with lower levels of education.  The level of scientific 
literacy is likely to be higher in those individuals studied and therefore results may be 
applicable to individuals with lower levels of literacy. 
 
The respondents’ answers to the interpretation questions were enlightening.  Their 
impressions of alcohol and genetics were coded in order to glean further information.  
Because the majority of respondents noted that there was some sort of relationship we 






inheritable.  One respondent was confident enough to respond with exact percentages.  
They noted: “Variability (38-64%) of predisposition related to genetic factors (Science, 
Post-Baccalaureate)” While research has shown that alcohol dependency is very directly 
tied to environment (Theall, et al., 2009), only 23 respondents independently noted the 
environment in their response.  The more typical response was similar to “Genetics do 
matter, but are not the only important factor (Liberal Arts / Fine Arts, Post-
Baccalaureate)”  This indicates that the individuals responding were acknowledging that 
something else has an impact on alcohol dependency but were unwilling to take the next 
step and indicate that the environment has an impact.  This could mean that when 
examining the advertisement persons tend to relate only to the information presented to 
them and not consider what they likely know to be true in a different context.  It would 
be interesting to test this hypothesis with a focus group study which provided two sets of 
participants with different sets of information and determined how they limited 
themselves to what was presented and / or utilized their own experience to answer 
questions. 
 
As with many types of social research, the instrument may have had an impact on 
individual responses.  Further exploration utilizing different instruments and 
methodologies would be useful to confirm this research.  Because only one test from one 
company was utilized it is unclear what impact different tests and different 
advertisements would have on the results.  In addition, by presenting the survey online 
and allowing respondents to refer back to the materials this study may be an over-
estimate of respondents’ actual retention and more of a review of their strict 
comprehension. 
 
This indicates that consumers may require more information than what is presented in 
the results of the studies by a certain company.  While the advertisement does give some 
background it is general descriptions of the condition.  Perhaps companies should be 
required to give a more comprehensive scientific literature review in these types of 
advertisements.  It is clear that not all respondents have a clear and comprehensive 







Alcoholism was chosen as the test profile of choice because of the numerous social 
issues surrounding it.  Even when compared to other substance abuse disorders, alcohol 
dependency is more highly stigmatized.  Persons with alcohol dependencies are more 
likely to be held responsible for their addictions and provoke more negative emotions 
than other chemical dependencies (Schomerusl, Lucht, Holzinger, Matschinger, Carta, & 
Angermeyer, 2010).  Because of its prevalence, it represents a type of disorder where 
persons are likely enough to be familiar with it but unlikely to have extensive knowledge 
of the topic.  There are biases that result from additional knowledge of the subject.  One 
respondent noted that they had experience with Native Americans and as a result 
believed there to be a genetic influence.  While some of this previous knowledge exists 
in the survey results, utilizing this particular test instead of something as familiar as 
breast cancer likely limited that impact.  
 
Although it was limited, it is important to note that racial and other biases do exist in the 
population (as noted previously) and that they might be influencing decision making 
regarding genetic testing.  People’s inherent knowledge may be a key factor and force a 
decision regardless of the information presented in an advertisement or website.  Future 
research should focus on identifying what portion of potential users have already 
decided to utilize DTC genetic testing before doing online research. 
 
In order to determine whether respondents identified a difference between family and 
blood relatives receiving test results (and the meaning of each) two questions were asked 
to that effect.  While the percentage of persons responding that they would not be 
interested remained similar, 8 individuals changed their response.  This indicates that for 
some people having a blood relative receive a positive result is different than having a 
family member receive one, and that these people may place a higher value on the 
genetic component.   
 
In general respondents indicated that they thought genes and alcohol were somewhat 
related.  The rest of the responses fell in a normal distribution around that response.  
While this indicates a broad understanding of the relationship, it is clear by responses to 






population.  Although the information was made readily available as they answered the 
survey, a large number of participants were unable to articulate the relationship between 
one of the genetic markers included in the test and alcoholism.  As a result of this gap, 
individuals may believe that they have a greater understanding than they actually do.  
Due to the publicity that genetics have received over the past two decades it is possible 
that individuals have a false perception of expertise when it comes to all genetic tests as 
a result of being informed through lay media which, in general, is unable to convey the 
full complexities of an issue. 
 
Developing safeguards against this type of mentality may be another place for 
implementation.  Perhaps individuals who receive certain tests should be quizzed on the 
impacts of those tests and the overall diseases and their relationships to genetics.  
Informed consent is a concept which has been common to U.S. medical practice for over 
50 years (Salas).  Engaging patients in a program to ensure informed consent may assist 
in the incorporation of correct information in to their decision making processes.  
 
In considering informed consent, we must first examine the language utilized in 
discussions between doctors and patients.  The language which is used by doctors and 
scientists is one with unique rules and subtleties which may not effectively communicate 
the risk to potential research subjects or patients.  Without even knowing it, researchers 
make assumptions about the knowledge base of the research participant.  Even when 
materials are utilized to measure understanding, such as questionnaires the participant 
may respond correctly but still not understand the impact of the risk or the full meaning 
of the question.  For example, if a doctor were to tell a patient that the risk from a drug 
could include a blood clot and the patient answers on the quiz that blood clots are a 
potential risk; the doctor has not truly assessed the participant’s understanding of the 
risk.  Because the doctor knows that blood clots can cause heart attacks and stroke he 
assumes that the patient understands this as well, but it is possible that this may not be 
the case at all. When this information is presented in an advertisement it forces the 
discussion to become unidirectional and removes the ability of the patient to question 







With a topic such as genetics, science is continually moving forward and in some cases 
even the individuals presenting information may not fully understand that information.  
Therefore a question arises as to how it can be possible to inform patients of all the risks.  
One example of this in the medical community is that of Viagra.  Scientists at Pfizer 
originally developed the drug to treat hypertension.  However, during clinical trials they 
discovered that the drug was much more efficient at aiding individuals with erectile 
dysfunction (Boolel, Alan, & Ballard, 1996).  This “side-effect” had not been considered 
by the scientists until it was reported by participants and was not likely part of their 
informed consent briefing.  While this side-effect was not extraordinarily harmful it does 
demonstrate the point that science is ever evolving and that it is unlikely that researchers 
will even be able to communicate all the potential risks of a new procedure or drug 
because they themselves are still trying to determine what those are.  Currently, genetic 
testing falls into this category, but because the link between the tests and outcomes is 
less clear, it is even more likely that the individuals advertising for the test are unaware 
of all of the potential implications of a positive or negative result. 
 
While complete informed consent may be a lofty goal, the idea of ensuring equality of 
information should be carried into the realm of DTC genetic testing.  While the down-
stream implications are not well established, it is clear that when there is a potential for 
negative consequences, patients need to be as well informed as is possible, both of the 
scientific possibilities before the test is administered and of what the results truly mean. 
 
The results of this study indicate that there may be a disparity of information in terms of 
ensuring that consumers have the same understanding of the tests as those who market 
those tests.  In a perfect economy, one would expect a true equality of information 
between producers and consumers; however it is clear that in this instance there is a 
better understanding of the product by the producer than the consumer.  It is unclear 
what the final impact this disparity of information might have and future research should 
focus on determining the extent of the disparity and what impacts, if any it has on 







49% of respondents indicated that ethnicity had no impact on the relationship between 
genetics and alcohol dependency.  Given that the studies were ethnicity dependent and 
that this was noted in the advertisement this response is somewhat startling.  The 
number of people who did not either understand or missed this notation may indicate 
that it is not presented clearly in the advertisement. While some individuals may take the 
time to look at the studies referenced by the advertisement it may be unlikely that most 
would take the time to do so.  If an individual trusts an advertisement citing scientific 
literature to be accurate and does not understand the true meaning of the literature itself 
it is likely that they will not understand whether the information applies to them.  If this 
mistake is not corrected, the individual may purchase a test which is of no value to them, 
or worse, they could apply misleading test results to themselves and make decisions 
based on false information. 
 
There was also confusion when respondents were asked how many people were studied 
to identify a relationship presented in the advertisement.  While 64% did choose the 
right answer, more than one-third chose incorrectly or did not answer the question at all.  
Again this may be a result of the information not being presented clearly or persons not 
being able to interpret it in the way it was intended.  Statistically, study size has a large 
impact on the conclusions that can be drawn from a given research project.  The inability 
of consumers to identify this critical component of the projects is concerning.  Further, 
the results of this study may indicate that the underlying concept of statistical 
significance is not apparent to this population.  Future studies should examine the ability 
of consumers to both understand why study size is important and whether they are able 
to readily identify the size of a particular research sample. 
 
These two results indicate that there may be a base set of information that needs to be 
presented in every one of these advertisements which creates a common understanding 
of certain terms.  Ethnicity is referred to in the advertisement but nowhere is it directly 
stated which ethnicities were studied to get these results.  The same is true of the sample 
sizes.  While the ad presents the number of people in text and as a diagram it is clear that 
a significant portion of this population was unable to glean this information.  It may be 






similar to that of the conventions the pharmaceutical industry must follow when 
advertising to the general public (US Food and Drug Administration, 2011). 
 
Whether or not there was significant interest in the condition may have had an impact on 
the results.  Excessive interest may lead to a group of individuals with extensive 
knowledge of the disease and its genetic relationships.  Conversely, a bias toward 
individuals with a lack of interest may indicate a lack of understanding which may result 
in no knowledge of the disease.  Both of these situations are less than desirable if we are 
attempting to use this population as an analog to the target consumers of these tests. 
 
When asked to identify their interest on a likert scale the majority noted “somewhat 
interested” with a normal distribution of responses on either side.  Therefore it appears 
that a moderate amount of interest existed in this population.  This is what would be 
expected and therefore helps to normalize this population.  There is likely no skewing of 
the data as a result of excessive or no interest in the condition.   
 
In order to see what respondents’ actions might be if they did receive a positive result 
for this test they were asked what their next step would be.  The majority indicated that 
they would talk to their physician.  As noted previously, physicians act as gatekeepers in 
many instances and serve as a guide for most individuals as they navigate health care.  
Having an informed and independent party available throughout a process has been 
demonstrated to have better outcomes.  From a policy perspective this is important 
because it identifies that most people want a physician involved in this discussion and 
therefore mandating that option or a similar one may be palatable to a majority of 
people. 
 
A secondary individual responsible for assisting in decision making is often made 
available in the form of a health care advocate.  These advocates can assist patients in 
making complex clinical decisions as well as aiding in navigating the complex insurance 
and legal issues inherent in the U.S. healthcare system.  In times of emotional distress 
and when the individual is incapable of making decisions, oftentimes an advocate will 






immediate threat.  Typically the individual has clinical training and a good working 
knowledge of the healthcare system.  Although debated, nurses have taken on this role 
and have been used in a structured model as patient advocates (Hewitt, 2002). 
 
While not entirely applicable, this model may contain certain concepts which would be 
applicable in the DTC testing arena.  For example, it may be preferable to require 
individuals have a consult with a specially trained social worker or other third party 
before making any decision based on genetic test results, similar to the idea of a patient 
advocate.  With the advent of genetic testing for clinical purposes a new profession has 
been developed to act in this role.  Genetic counselors now exist and are well organized 
as a profession with a national professional society (National Society of Genetic 
Counselors, 2012).  Perhaps these professionals should be made available at no cost to 
the consumer to be utilized as independent resources for persons who decide to purchase 
DTC testing.  Patients could be notified by DTC genetic testing companies before or 
after purchasing to ensure that those who are interested in genetic tests have an 
additional source of information and a bidirectional information flow not provided by 
the advertisements. 
 
23 and Me utilizes a term “established research report.” After numerous search attempts 
on their website it was unclear how they defined this.  In order to determine how other 
might interpret this statement, respondents were asked what they thought it meant.  
There was wide variability in the answers but a major theme in responses was that 
established reports were peer reviewed.  Most answers were similar to that of one 
respondent who stated, “A work of scientific research that has been subjected to peer-
review within a discipline (Engineering / Computer Science, Post-Baccalaureate.)” 
 
Interestingly, three individuals noted that there was no real significant meaning to this 
title.   One respondent noted “I am not familiar with this terminology.  And, I must say, I 
have been in the business of scientific research for a long time; but I don't attach any 
particular significance to the modifier ‘established’ in this context. (Engineering / 
Computer Science, Post-Baccalaureate.)”  Indeed, an internet search for the term 






term from any organization outside of 23 and Me.  Again it is clear that certain terms 
need to be defined as industry standards in order to ensure that all parties have an equal 
understanding of the information.  
 
When asked what journals contained the studies reported in the majority of persons 
simply copied the abbreviations verbatim from the advertisement.  A few made attempts 
at guessing the abbreviations and some even attributed their response to an internet 
search.  One respondent even noted that “Would’ve b[e]en n[i]ce if they had included 
the full titles of each (Unknown, Baccalaureate).”  Given this, it is unclear how reliable 
internet sources utilized by these individuals will be.  While the persons who noted an 
internet search did answer correctly this may not be true in all cases.  Having individuals 
rely on third parties to get their information is not a reliable and consistent way to 
provide that information.  In addition, it is unclear how individuals would be able to 
access the primary literature on the subject and whether the abbreviations presented 
were clear enough to help users find the journals. 
 
Only 12 individuals correctly identified a “SNP.”  Of those 12, 4 noted using an internet 
search.  One individual went so far as to say: “According to the web definition, it is a 
Single Nucleotide Polymorphism; I don't know the science behind it but it is a DNA 
sequence variation that was used in the cited studies (Liberal Arts / Fine Arts, Post 
Baccalaureate).”  This individual admits to not understanding the science but was able to 
provide an adequate definition of the term.  This ability to recite definitions with no 
substance behind the understanding of those definitions is indicative of a lack of true 
understanding of the material.  Further research should be completed in order to 
determine whether individuals who fall into this category of understanding actually 
believe that their knowledge is sufficient to make decisions. 
 
Because the term SNP is used in the advertisement it would be prudent for consumers to 
understand the meaning of that term, however it is clear that the vast majority of this 
sample did not know that answer.  It is standard convention to define acronyms 






information it would be important to define acronyms such as SNP in a clear and readily 
identifiable manner.   
 
7% of respondents failed to understand the fundamental difference between a positive 
and negative test result.  This is a concern not just in this arena but also for medical 
reports in general.  It also indicates that persons need results explained by someone who 
is able to ably communicate the meaning of test results.  From a policy perspective this 
reinforces the idea that people may need a health professional to help them navigate 
these results.  As a gatekeeper a physician may be able to help explain these results in an 
individual way which makes sure that every person understands what their result means 
specifically to them.  If it is impractical for a physician with sufficient training and 
education regarding genetic testing to serve this purpose, it may be beneficial to utilize 
genetic counselor’s to provide these services to patients. 
 
Being “positive” and “negative” have different connotations in medical language and 
popular culture.  In medicine being ‘positive’ means that a patient has a certain factor, 
trait, or pathogen.  It is not necessarily a good or beneficial trait.  Perhaps the best 
example of this would be in reference to HIV.  Being HIV positive indicates that you 
have live virus particles in your body.  This is, contrary to popular consensus, not a 
‘positive’ or good state.  The ‘positive’ test result counter-intuitively identifies a 
negative state.   Over time the confusion regarding positive and negative in context has 
lessened but as we can see with genetic testing there may still be a significant portion of 
the population that confuses the popular understanding of ‘positive’ with the medical 
definition. 
 
Overall, the results of this study indicate that there is a lack of understanding of the 
material presented in this manner.  Attributing  a cause for this is difficult but given that 
several authors have published concerns regarding this practice and the fact that the 
majority of respondents were well educated in related fields it is likely that there is a 
disconnect between what information is presented how it is interpreted.  The result of 
this disconnect is a dangerous situation wherein individuals firmly believe they 






unnecessary treatment and difficulties which may be preventable with better 
information. 
 
From a policy standpoint it appears that individuals would support requiring a physician 
or other qualified professional to interpret results with a patient.  In addition it may be 
necessary to regulate these advertisements in the same way prescription drug 
advertisements are regulated.  While there are concerns that the actual information is 
useful, perhaps a less invasive approach would be to make sure that the information is 
comprehendible by a wide majority of consumers and require an unbiased professional 
be available for interpretation questions.  This could be accomplished through a 
regulatory commission setting standards on what and how items can be presented or an 
independent third party assigned to review information with patients who receive these 
tests.  
 
Precedent has been set for regulation in the pharmaceutical industry.  Companies are 
required to give information regarding side-effects to consumers in their advertisements.  
One could argue that mental anguish can cause significant health issues on par with the 
numerous side effects that pharmaceutical companies are required to list (i.e. high blood 
pressure). While there is limited literature linking genetic tests to negative physical 
impact there is currently evidence and debate regarding this issue for a similar screening 
and non-invasive test. 
 
Currently, a debate exists regarding prostate cancer screening utilizing prostate specific 
antigen (PSA) and the potential mental anguish it causes.  Once a high PSA is found in a 
man he often proceeds to biopsies and further treatment, even when that treatment may 
not be considered beneficial.  For ‘peace of mind’ many men elect to have surgery or 
radiation therapy when it may be in his best interest to not actively treat the cancer 
(Denenberg, Melhado, & Steiner, 2006).  Genetic tests may lead to similar thinking.  
There have been instances where women have elected to have bi-lateral mastectomies 
when no cancer has been found but a genetic test has indicated that they are at a higher 
risk for breast cancer (Smith & Issacs, 2011).  The test is not 100% predictive; therefore 






with any surgery and choosing elective surgery without proper indication has the risk of 
leading to negative outcomes for the patient.   Merely the risk of having a future 
potential health impact can lead some individuals to take unwarranted action.  By 
ensuring that patients understand their genetic information completely it may be possible 
to limit some of these unnecessary and costly medical procedures.  Because of the 
complexity of this information and the indirect quality of the side-effects it may be 
beneficial to have an independent third party review this issue with patients and help 
them decide whether or not to be tested for each trait they wish to test for.   
 
While studies showing direct links between testing and poorer health outcomes are rare 
because of the multiple steps involved, the logical steps are clear.  This research 
demonstrates and a clear disconnect between this population’s understanding of genetics 
and clinical information.  Further research needs to be done in order to verify and 
expand these results to other populations but this preliminary research suggests that 
there is clearly disconnect between what is presented and what consumers perceive.  
 
Due to the personal nature of the subject, the medical implications and the continuing 
expansion of genetic knowledge the question of regulating people’s genetics is a 
sensitive issue.  That considered, there are various instances of local and national 
governments intervening on behalf of consumers, especially when health and welfare of 
individuals is involved.  The primary example of this is the food and drug 
administration, which at a federal level protects consumers from false claims and 
misleading advertising from medical equipment and pharmaceutical companies (Food 
and Drug Administration, 2011).  The findings presented here certainly support some 
type of intervention.  It is clear that while consumers may believe they understand these 
complex relationships, a large percentage do not.   
 
Because these tests are still primarily in their infancy, their usability in a clinical setting 
is unclear.  We need to be certain that consumers understand the information presented.  
If someone chooses to obtain this information at a fair price then they deserve to fully 
understand it.  The fact that this issue applies in a market where a person’s health is at 






addressed here, this should also be a consideration for government intervention.  In 
cases where the market has failed to provide equality of information it is the 
government’s role to ensure that all parties understand the transaction they are about to 
make.  This study indicates that this relationship may exist and while further research 
needs to be completed it appears that there may be a need for intervention.  Because the 
tests may have direct impacts on an individual’s health the need is more immediate. 
 
There are several limitations to this study which should be improved upon in further 
research.  Because of the nature of the survey tool, respondents were able to look at the 
advertisement while answering questions.  The result of this is that the answers may not 
have been a good indicator of the actual retention of information, but rather simple 
interpretation of what was available.  Therefore the answers are not a good measure of 
retention.  Future research should prevent respondents from viewing the form after a 
certain time in order to measure this.  However, if individuals are unable to answer 
questions while they still have the information in front of them the likelihood of 
retention is diminished. 
 
The nature of the survey itself is likely to have had an impact on the results.  Allowing 
individuals to be able to review the advertisement while they answered questions does 
prevent us from understanding how much information was retained.  One respondent did 
note that in a response saying “Just FYI as a respondent, I found myself going back to 
the advertisement after reading each question and doing a scavenger hunt for the 
answers to your questions, looking for information that I would not have necessarily 
looked for on my own.  If you want to measure what people comprehend from 
advertisements, perhaps instruct the respondent to spend five minutes reading the 
advertisement then switching to a new page to answer comprehension questions… 
(Unknown, Post-Baccalaureate).”   I would agree with this respondent; however what 
the survey does tell us is how much information people can garner while they still have 
the advertisement at their disposal.  One could assume that if a respondent could not 
answer accurately when they still had the advertisement, the respondent would be less 







Because respondents were allowed to take the survey on their own, there may be other 
impacts to the results.  As previously noted, several respondents admitted to using an 
internet search to help them find answers.  It is also possible that respondents had help 
from colleagues or other persons near them at the time they took the survey.  The 
decision was made not to limit time or location of the survey in order to provide privacy 
and security to respondents.  However, by not monitoring their activity it is possible that 
the answers provided are not an accurate reflection of each individual’s true 
comprehension. 
 
This sample was skewed toward highly educated individuals.  As a result this may not 
be an accurate measure of the general population.  However, if it is clear that a group of 
highly educated individuals has difficulty understanding the information it is likely that 
less educated groups may have similar if not more exaggerated difficulties.  
 
In order to group answers coding exercises were completed on several questions.  By 
codifying answers there is a certain resolution lost in analysis.  Every effort was made to 
mention unique or specific answers in the discussion but it is likely that some specific 
knowledge is not accounted for here.  All answers to free text questions (blinded and 
randomized) are presented in Appendix B.   
 
The content of the survey instrument itself could be improved for future research.  The 
wording of several questions and their order may be improved upon to glean different 
responses.  Only one test was presented to the respondents and one test is certainly not 
indicative of all genetic testing.  However, the test was chosen with care as a 
representative of a disorder with which many people are at least somewhat familiar and 










Necessarily, policy consistently lags behind technological innovations.  It is impossible 
to determine the unintended consequences of a given technology before its widespread 
adaptation.  There are often both positive and negative impacts of any new technology 
and it is unlikely that DTC genetic testing will be any different.  That said, given the 
potential health impacts at both individually and at a population level, it is critical that 
we attempt to anticipate and mitigate any potential negative consequences of this 
technology.  Ensuring consumers have the best possible knowledge is the first step in 
that process.   
 
This research provides the first look at this issue and informs us that in a relatively well 
educated population there are discrepancies in the understanding of one particular 
advertisement. However there is still much work to be done in order to determine 
whether regulation is necessary at a national level.  Outstanding issues include 
reviewing similar advertisements and websites with consumers, establishing the 
retention of the information by consumers and determining what political and economic 
tolerance may be for including gatekeepers in the process of obtaining genetic 
information.  Further studies should focus on these topics to help determine if policies 
are required for these tests. 
 
Genetic testing is currently being adopted by individuals but it may be that those 
individuals do not understand the implications of this new technology.  It is clear that 
further research is needed to better understand how individuals interpret genetic testing 
advertisement.  However, based on the information presented here, it appears reasonable 
that some policy measures be put in place to assist consumers in processing this 
information.  Just as with prescription drugs it may be important to regulate not only 







Currently, the FDA is moving towards some form of regulation in this arena.  Letters 
have been sent to major manufacturers requesting changes be made to their advertising 
practices but to date, no serious interventions have been undertaken.  Information similar 
to what is presented here has the opportunity to inform those decisions in a meaningful 
way.  While this research is limited in scope, it does indicate that there is reason to move 
forward with larger and more complex studies in a similar manner.  National policy 
measures requiring communication with a licensed professional may be the most 
palatable and effective step to regulating these tests.  
 
At least in this population, there is a disconnect between an individual’s perceived 
expertise and their true understanding of the information presented in this advertisement.  
Because this population has a higher average education than the general population we 
can presume that this trend may prove true or indeed worsen in a broader sample.  In 
general it appears that this population believes they have a better understanding of the 
information than they actually do.  In addition a definitive line needs to be drawn in 
terms of what patients actually need to know and at what level they need to understand 
this information.  Given the major decisions that can be made based on the results of 
these tests, a fundamental misunderstanding of their meaning may be devastating to a 
patient’s health in the long-term. 
 
Whether or not government regulation is required in this arena is dependent upon a 
multitude of factors, including consumer understanding, consumer decision making, and 
health outcomes as a result of those decisions.  Any break in this chain could result in a 
devastating impact to individual and public health.  This research focuses on the first 
link in that chain and indicates that there is a need for further work.  Without adequate 
patient understanding the other two links are necessarily impacted as misinformed 
decisions can be quite dangerous especially when it comes to a person’s health. This 
research indicates that there is a good possibility that individuals who purchase these 
tests without further guidance are currently misinformed and would benefit from an 
increased regulatory structure requiring clear communication and personalized 
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Welcome, Albert Blankley ( logout )My Surveys Help
Direct-to-Consumer Genetic Testing
You are invited to join a research study which looks at Direct-to-consumer (DTC) genetic testing. In this research study, we are investigating how people
understand information presented to consumers by DTC genetic testing companies.
You will be asked to complete a short survey, in which you will be presented with a screenshot from a website and asked questions about the information
presented, as well as some demographic questions and some questions relating to your background in biological science. We think this will take you
between 5 and 10 minutes.
You may stop participating at any time. If you decide to leave the study simply close the window in which the survey is presented.
CONFIDENTIALITY
Your name will not be used when data from this study are published.  All survey results are anonymous and are not linked to a specific user. Every effort will
be made to keep all personal information confidential.  As the primary investigator, only Albert Blankley will have access to the data and there is no link
between who responded to the survey and the specific answers you provide.
Participation in this study is voluntary. You have the right not to participate at all or to leave the study at any time. Deciding not to participate or choosing to
leave the study will not result in any penalty or loss of benefits to which you are entitled.
If you have any questions or concerns please feel free to contact me at aab8038@rit.edu.
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 Asian / Pacific Islander
 Caucasian
 Latin / South American
 Native American
 Other:  
Demographics
1. What is your age?
2. What is your sex?
3. Education (please select one):
4. If you have a received a college education (associate's or more) please indicate your major
5. What is your highest terminal degree?
6. What is your current occupation?
7. Ethnicity


























8. What are your impressions of alcohol dependency and genetics
9. How many studies are described by this advertisement?
10. If you had a family member who had a dependency on alcohol would you be interested in getting a genetic test for
yourself?
11. If you had a blood relative who had a dependency on alcohol would you be interested in getting a genetic test for
yourself?
12. What is the relationship between marker RS27072 and alcohol dependency?
13.
14. Does ethnicity have an impact on this relationship?
15. If so, how?
















 Seek more information on the condition on the internet
 Talk to my doctor about my risks







17. Approximately how many people’s genetics were studied to determine the relationship between marker
RS18001197 and alcohol dependency?
18. What would you do if you received a test result that indicated you had this gene?
19. Where did you receive the majority of the information?
Science Background
20. What is an established research report?






21. What journals did the research stem from?
22. What is a SNP?
23. Susie requested that this analysis be done for her. The result stated that she had an increased risk for alcohol
dependency. The letter from the lab said that her test was ____________.
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